The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Cell-Based Ophthalmic Therapies Market Compare Between 2026 And 2030?
The cell-based ophthalmic therapies market has seen remarkable expansion in its size over recent years. It is anticipated to increase from $1.48 billion in 2025 to $1.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 20.9%. The drivers for this growth in the past can be linked to the scarcity of treatment options for degenerative eye diseases, the rising prevalence of retinal and corneal disorders, an expanding aging demographic, growing awareness surrounding regenerative medicine, and the development of ophthalmic research infrastructure.
The cell-based ophthalmic therapies market size is projected to experience substantial growth in the coming years, with an anticipated increase to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 20.5%. This expansion is driven by advancements in stem cell and gene editing technologies, increasing investment in regenerative ophthalmology, rising regulatory approvals for cell-based therapies, growing demand for long-term vision restoration solutions, and the expansion of specialized ophthalmic treatment centers. Key trends for this period include increasing adoption of stem cell and gene therapies for vision restoration, a rising focus on regenerative treatments for retinal and corneal disorders, growth in clinical trials for cell-based ophthalmic therapies, the expansion of personalized and precision ophthalmic treatments, and improved long-term outcomes compared to conventional ophthalmic therapies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27246&type=smp
What Key Factors Are Affecting The Cell-Based Ophthalmic Therapies Market Demand?
The escalating occurrence of ophthalmic disorders is anticipated to fuel the expansion of the cell-based ophthalmic therapies market moving forward. Ophthalmic disorders are conditions or illnesses affecting the eyes, leading to visual impairments or harm to eye health. These disorders are becoming more common as the elderly demographic is increasingly susceptible to age-related eye conditions, which cause vision loss alongside longer lifespans. Cell-based ophthalmic therapies function by repairing or substituting impaired retinal and eye cells to regain sight and avert further harm, simultaneously fostering regeneration and improving overall eye functionality. For instance, in August 2024, the Welsh Government, a UK-based government agency, reported that ophthalmology departments in Wales registered more than 35,000 admissions during 2023-24, indicating a 5.8% rise from 2022-2023. Consequently, the rising frequency of ophthalmic disorders is propelling the growth of the cell-based ophthalmic therapies market.
How Is Segmentation Applied In The Cell-Based Ophthalmic Therapies Market Segment Analysis?
The cell-based ophthalmic therapies market covered in this report is segmented –
1) By Therapy Type: Stem Cell Therapy, Gene Therapy, Tissue Engineering
2) By Application: Retinal Disorders, Corneal Disorders, Glaucoma, Other Applications
3) By End-User: Hospitals, Ophthalmic Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Stem Cell Therapy: Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Retinal Pigment Epithelium Cell Therapy, Limbal Stem Cell Therapy
2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector Based Gene Therapy, In-Vivo Gene Therapy, Ex-Vivo Gene Therapy, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy
3) By Tissue Engineering: Bioengineered Corneal Tissue, Amniotic Membrane Transplantation, Hydrogel-Based Scaffolds, Synthetic Polymer Scaffolds, Decellularized Tissue Constructs
What Trends Are Affecting The Growth Of The Cell-Based Ophthalmic Therapies Market?
Leading companies in the cell-based ophthalmic therapies market are primarily focused on developing advanced treatments, such as allogeneic cell therapy, to address unmet needs in the treatment of corneal endothelial diseases. Allogeneic cell therapy describes a medical approach that utilizes stem cells or other cells donated by a genetically different individual of the same species to repair or replace damaged tissues or treat various diseases. For instance, in September 2024, Aurion Biotech, Inc., a US-based clinical-stage biotechnology company, announced the commercial launch of Vyznova (neltependocel) in Japan. This product is specifically designed for the treatment of bullous keratopathy, a debilitating condition affecting the corneal endothelium. Vyznova is recognized as the first approved allogeneic cell therapy specifically targeting corneal endothelial disease, having secured both regulatory and reimbursement approvals in Japan.
Who Are The Companies Participating In The Cell-Based Ophthalmic Therapies Market Environment?
Major companies operating in the cell-based ophthalmic therapies market are F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc.
Get The Full Cell-Based Ophthalmic Therapies Market Report:
Where Is The Cell-Based Ophthalmic Therapies Market Primarily Concentrated By Region?
North America was the largest region in the cell-based ophthalmic therapies market in 2025. The regions covered in the cell-based ophthalmic therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cell-Based Ophthalmic Therapies Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Cell-Based Ophthalmic Therapies Market 2026, By The Business Research Company
Breathable Membranes Market Report 2026
https://www.thebusinessresearchcompany.com/report/breathable-membranes-global-market-report
Specialty Breathable Membranes Market Report 2026
Vacuum Insulation Market Report 2026
https://www.thebusinessresearchcompany.com/report/vacuum-insulation-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model